Drug recall · March 25, 2020
Lisinopril/HCTZ 20mg/12.5mg Tablet recall
Why: Presence of Foreign Tablets/Capsules: This is a spin-off recall of D-1581-2019 due to a product complaint where one of Lupin's Fenofibrate 145mg was observed in the 500 s count product bottle.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lisinopril/HCTZ 20mg/12.5mg Tablet, QTY: 30 tablets per blister card, MFG: Lupin Pharma Baltimore, MD 21202, NDC 68180-0519-02 (Original NDC of 500 count bottle); 70518-0382-03 (Repackaged NDC for blister cards).
- Lots / codes
Lot #: J0322819-091418, Exp: 09/30/2019
- Quantity
- 480 tablets
- Company
- RemedyRepack Inc., Indiana, PA
- Distribution
- PA
- Initiated
- August 5, 2019 · Voluntary: Firm initiated
- Classified
- March 16, 2020
- Reported
- March 25, 2020
- Ended
- June 2, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydrochlorothiazide / lisinopril
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.